NASDAQ:RNLX

Renalytix AI Short Interest Ratio and Short Volume

$26.68
+0.66 (+2.54 %)
(As of 04/15/2021 04:30 PM ET)
Add
Compare
Today's Range
$25.21
Now: $26.68
$27.25
50-Day Range
$22.80
MA: $26.70
$31.13
52-Week Range
$9.91
Now: $26.68
$32.12
Volume52,791 shs
Average Volume131,779 shs
Market Capitalization$961.12 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Short Interest

Renalytix AI (NASDAQ:RNLX) Short Interest Data

Current Short Volume352,100 shares
Previous Short Volume308,600 shares
Change Vs. Previous Month:+14.10%
Dollar Volume Sold Short$8.48 million
Short Interest Ratio / Days to Cover2.6
Last Record DateMarch, 31 2021
Outstanding Shares36,024,000 shares
Percentage of Shares Shorted0.98%
Today's Trading Volume52,791 shares
Average Trading Volume131,779 shares
Today's Volume Vs. Average-59.94%

Short Interest Over Time


Renalytix AI (NASDAQ:RNLX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2021352,100 shares $8.48 million +14.1%N/A2.6 $24.08
3/15/2021308,600 shares $8.36 million +243.7%N/A2.3 $27.08
2/26/202189,800 shares $2.55 million -70.5%N/A0.8 $28.44
2/12/2021304,100 shares $6.93 million +225.9%N/A3 $22.80
1/29/202193,300 shares $2.45 million -69.4%N/A1 $26.22
1/15/2021305,200 shares $7.73 million No ChangeN/A3.7 $25.33

Renalytix AI (NASDAQ:RNLX) Short Interest FAQ

speech bubbles
speech bubbles











What is Renalytix AI's current short interest?

Short interest is the volume of Renalytix AI shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 352,100 shares of RNLX short.

What is a good short interest ratio for Renalytix AI?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Renalytix AI currently has a short interest ratio of 3.0.

Is Renalytix AI's short interest increasing or decreasing?

Renalytix AI saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 352,100 shares, an increase of 14.1% from the previous total of 308,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Renalytix AI's short interest compare to its competitors?

0.00% of Renalytix AI's shares are currently sold short. Here is how the short interest of companies in the industry of "medical laboratories" compare to Renalytix AI: Veracyte, Inc. (0.00%), Burning Rock Biotech Limited (1.13%), Fulgent Genetics, Inc. (34.55%), Genetron Holdings Limited (0.55%), Castle Biosciences, Inc. (15.48%), DermTech, Inc. (0.00%), RadNet, Inc. (1.92%), Personalis, Inc. (0.00%), Celcuity Inc. (0.23%), and Centogene (4.30%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Renalytix AI stock?

Short selling RNLX is an investing strategy that aims to generate trading profit from Renalytix AI as its price is falling. Renalytix AI's stock is trading up $0.66 today. To short Renalytix AI stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Renalytix AI will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Renalytix AI?

A short squeeze for Renalytix AI occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNLX, which in turn drives the price of the stock up even further.

How often is Renalytix AI's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNLX, twice per month. The most recent reporting period available is March, 31 2021.



This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.